Faculty Opinions recommendation of Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733519001.793576228 ◽

2020 ◽

Author(s):

Pedro Machado

Keyword(s):

Ankylosing Spondylitis ◽

Dose Finding ◽

Phase 2 ◽

Proof Of Concept ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733519001.793552052 ◽

2018 ◽

Author(s):

Hill Gaston

Keyword(s):

Ankylosing Spondylitis ◽

Dose Finding ◽

Phase 2 ◽

Proof Of Concept ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Review for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Review for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Review for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v1/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Decision letter for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Review for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

A 12‐week, randomized, double‐blind, placebo‐controlled, four‐arm dose‐finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13928 ◽

2019 ◽

Vol 22 (4) ◽

pp. 566-573 ◽

Cited By ~ 1

Author(s):

Yuan‐Di Halvorsen ◽

Geoffrey Walford ◽

Tara Thurber ◽

Heidy Russell ◽

Monica Massaro ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Author response for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v3/response1 ◽

2019 ◽

Author(s):

Yuan‐Di Halvorsen ◽

Geoffrey Walford ◽

Tara Thurber ◽

Heidy Russell ◽

Monica Massaro ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Author Response ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Decision letter for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Review for "A Twelve‐Week, Randomized, Double‐Blind, Placebo‐Controlled, Four‐Arm Dose‐Finding Phase 2 Study Evaluating Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13928/v2/review3 ◽

2019 ◽

Author(s):

Manuel Perez-Maraver

Keyword(s):

Type 2 Diabetes ◽

Dose Finding ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text